Inventor · disambiguated record
Charles F. Jewell
Also filed as: JEWELL CHARLES · JEWELL CHARLES F · JEWELL CHARLES FRANCIS · JEWELL JR CHARLES F
6 granted patents·5 pending applications·173 citations·filing 1983–2017
85Inventor score
Files withSANDOZ PHARMACEUTICALS CORP2BIOGEN IDEC INC1BURGIS ROBIN1CELGENE CAR LLC1COPPOLA GARY MARK1
Top patents by PatentIndex Score
11 records- 0193US4625039A4-trisubstituted silyl protected hydroxy-6-oxo-tetrahydropyran-2-yl-aldehyde intermediatesSANDOZ PHARMACEUTICALS CORP·Filed 1983·Granted Nov 25, 1986·39 cites·4 claims
- 0291US8293923B2Indazole derivatives as modulators of interleukin-1 receptor-associated kinaseGUCKIAN KEVIN·Filed 2007·Granted Oct 23, 2012·52 cites·27 claims
- 0391US4677211APreparation of lactonesSANDOZ PHARMACEUTICALS CORP·Filed 1985·Granted Jun 30, 1987·46 cites·16 claims
- 0485US4650890APreparation of olefinic compounds and intermediates thereofSANDOZ CORP·Filed 1985·Granted Mar 17, 1987·28 cites·15 claims
- 0572US7291635B25-substituted 1,1-dioxo-1,2,5,-thiadiazolidin-3-one derivativesNOVARTIS AG·Filed 2003·Granted Nov 6, 2007·7 cites·16 claims
- 0669US11542492B2Ligand-directed covalent modification of proteinCELGENE CAR LLC·Filed 2017·Granted Jan 3, 2023·1 cites·7 claims
- 0751US2008139576A15-Substituted 1,1-Dioxo- 1,2,5- Thiadiazolidin-3-One DerivativesCOPPOLA GARY MARK·Filed 2007·Application pending·0 cites
- 0850US2011092505A1Organic compoundsBURGIS ROBIN·Filed 2009·Application pending·0 cites
- 0947US2011269244A1Ligand-directed covalent modification of proteinPETTER RUSSELL C·Filed 2010·Application pending·0 cites
- 1046US2012142685A1Organic compoundsDOBLER MARKUS ROLF·Filed 2008·Application pending·0 cites
- 1145US2011021513A1Modulators of interleukin-1 receptor-associated kinaseBIOGEN IDEC INC·Filed 2007·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Charles F. Jewell files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →